Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10

Immunology

Volumn 94, Issue 2, 1998, Pages 129-134

  Manickan, E ^a   Daheshia, M ^a   Kuklin, N ^a   Chun, S ^a   Rouse, B T ^a,b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b M409 Walters Life Sciences Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; HERPES SIMPLEX VIRUS; IMMUNOMODULATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; FEMALE; GENE THERAPY; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; PLASMIDS; VACCINIA;

EID: 0031805593     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00496.x     Document Type: Article

References (24)

1. SCHWARZ A., GRABBE S., RIEMANN H. et al. (1994) In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J Invest Dermatol 103, 211.
2. WOLFF J.A., MALONE R.W., WILLIAMS P. et al. (1990) Direct gene transfer into mouse muscle in vivo. Science 247, 1465.
3. ROGY M.A., AUFFENBERG T., ESPAT N.J. et al. (1995) Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in mouse reduce immortality to lethal endotoxemia and also attenuate local inflammatory responses. J Exp Med 181, 2289.
4. DAHESHIA M., KUKLIN N., KANANGAT S., MANICKAN E. & ROUSE B.T. (1997) Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol 159, 1945.
5. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1989) Molecular Cloning, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
6. XIANG X.Q., SPITALNIK S., TRAN M., WUNNER W.H., CHENG J. & ERTL, H.C.J. (1994) Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132.
7. MANICKAN E., YU Z., ROUSE R.J.D., WIRE W.S. & ROUSE B.T. (1995) Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP-27. Viral lmmunol 8, 53.
8. MANICKAN E., FRANCOTTE M., KUKLIN N. et al. (1995) Vaccination with recombinant vaccinia virus expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1 + cells. J Virol 69, 4711.
9. MARTIN S., MOSS B., BERMAN P.W., LASKY L.A. & ROUSE B.T. (1987) The mechanism of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D and cytotoxic T cell. J Virol 61, 726.
10. FIORENTINO D.F., ZLOTINK A., VIERA P. et al. (1991) IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146, 3444.
11. BODGAN C., VODOVOTZ Y. & NATHAN C. (1991). Macrophages deactivation by interleukin 10. J Exp Med 174, 1549.
12. KASAMA T., STREITER R.M., LUKACS W., BURDICK M.D. & KUNKEL, S.L. (1994) Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 152, 3559.
13. D'ANDREA A., ASTE-AMEZAGA M., VALIANTE N.M., MA X., KUBIN M. & TRINCHIERI G. (1993) Interleukin 10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulating factor/interleukin-12 synthesis in accessory cells. J Exp Med 178, 1041.
14. RALPH P., NAKOINZ. I., SAMPSON-JOHANNES A. et al. (1992) IL-10, T-lymphocyte inhibitor of human blood cell production of IL-10 and tumor necrosis factor. J Immunol 148, 808.
15. BORSTEIN S.M., ELNER S.G., MEYER R.F. et al. (1984) Interleukin-10 inhibition of HLA-DR expression in human herpes stromal keratitis. Ophthalmology 101, 1529.
16. MATSUDA M., SALAZAR F., PETERSON M. et al. (1994) Interleukin-10 pretreatment protects target cells from tumor-and Allo-specific expression. J Exp Med 180, 2371.
17. DING L., LINSLEY P.S., HUANG L., GERMAIN R. & SHEVACH E.M. (1993) IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151, 1224.
18. SALAZAR-ONFRAY F., CHARO J., PETERSON M. et al. (1997) Downregulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. J Immunol 101, 3195.
19. UBRA M., ROMERO L.I. & KARASEK M.A. (1996) Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 184, 821.
20. SARVETNICK N. (1996) Mechanisms of cytokine-mediated localized immunoprotection. J Exp Med 184, 1519.
21. ULMER J.B., DECK R.R., DEWITT C.M., DONELLY J.J. & LIU M.A. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 51.
22. DOE B., SELBY M., BARNETT S., BAENZIGER J. & WALKER C.M. (1996) Induction of cytotoxic T-lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone-marrow-derived cells. Proc Natl Acad Sci USA 83, 8578.
23. SATO Y., ROMAN M., TIGHE H. et al. (1996) Immunostimulatory sequences necessary for effective intradermal gene immunization. Science 273, 352.
24. GROUX H., O'GARRA A., BIGLER M. et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Science 389, 739.